MORRISVILLE, N.C., May 10, 2012 /PRNewswire/ -- Electrophysiology thought leaders gathered to discuss the significance of posterior ablation in the treatment of arrhythmias, with presentations

Abstract Plus Session 35-02: Oral Presentation: "Combined Epicardial and Endocardial Ablation for Atrial Fibrillation: Single Center Experience in 100 Consecutive Patients"

On April 15th 2012, the Financial Times reported that Sanofi’s drug Multaq lost reimbursement in France and faced new restrictions in other countries.

MORRISVILLE, N.C., March 27, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that CEO John Funkhouser spoke at the American College

The Canadian Journal of Cardiology has published a focused update to the Canadian Cardiovascular Society's atrial fibrillation guidelines.